Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 18.35.
Forward PE Ratio (18.35) = Close Price ($336.34) / Consensus Forward EPS ($18.33)
FORWARD PE RATIO
18.35
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-7.86%
vs the sector median at left
Labcorp Holdings Inc.
Market Cap
$27.58B
Forward PE Ratio
18.35
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Labcorp Holdings Inc. (LH) | $27.58B | 18.35 |
| Quest Diagnostics Incorporated (DGX)vs › | $26.97B | 21.84 |
| Mettler-Toledo International Inc. (MTD)vs › | $28.19B | 29.48 |
| Medline Inc. (MDLN)vs › | $28.97B | 22.71 |
| Incyte Corporation (INCY)vs › | $25.91B | 33.97 |
| BioNTech SE (BNTX)vs › | $29.28B | N/A |
| West Pharmaceutical Services, Inc. (WST)vs › | $24.85B | 39.38 |
| Waters Corporation (WAT)vs › | $30.72B | 28.18 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $31.61B | 36.30 |
| STERIS plc (STE)vs › | $23.19B | 23.33 |
Trailing P/E
27.8
reported TTM EPS
Forward P/E
18.4
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $18.33 implies +51.6% EPS growth vs the reported trailing $12.09.
At today's $336.34 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $18.33 | $18.05 – $18.48 | 10 | 18.3x |
| 2027-12-31 | $19.86 | $18.92 – $20.33 | 12 | 16.9x |
| 2028-12-31 | $21.57 | $19.40 – $24.42 | 8 | 15.6x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
